Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)

Por Toi, Hirofumi, Tsujie, Masanori, Haruta, Yuro, Fujita, Kanako, Duzen, Jill, Seon, Ben K.
Publicado no Int J Cancer (2014)

Receptor-targeted anticancer therapy

Por Seon, Ben K., Haruta, Yuro, Matsuno, Fumihiko, Haba, Akinao, Takahashi, Norihiko, She, Xinwei, Harada, Naoko, Uneda, Shima, Tsujie, Masanori, Tsujie, Tomoko, Toi, Hirofumi, Tsai, Hilda
Publicado no Immunol Res (2010)

Endoglin-Targeted Cancer Therapy

Por Seon, Ben K., Haba, Akinao, Matsuno, Fumihiko, Takahashi, Norihiko, Tsujie, Masanori, She, Xinwei, Harada, Naoko, Uneda, Shima, Tsujie, Tomoko, Toi, Hirofumi, Tsai, Hilda, Haruta, Yuro
Publicado no Curr Drug Deliv (2011)